Weber, Yanik
Böck, Desirée http://orcid.org/0000-0001-8142-0629
Ivașcu, Anastasia
Mathis, Nicolas http://orcid.org/0000-0002-4051-8344
Rothgangl, Tanja http://orcid.org/0000-0001-7799-2413
Ioannidi, Eleonora I.
Blaudt, Alex C.
Tidecks, Lisa
Vadovics, Máté
Muramatsu, Hiromi http://orcid.org/0000-0003-1544-1493
Reichmuth, Andreas
Marquart, Kim F. http://orcid.org/0000-0001-7393-4398
Kissling, Lucas http://orcid.org/0000-0002-4989-0695
Pardi, Norbert http://orcid.org/0000-0003-1008-6242
Jinek, Martin http://orcid.org/0000-0002-7601-210X
Schwank, Gerald http://orcid.org/0000-0003-0767-2953
Article History
Received: 17 November 2023
Accepted: 14 February 2024
First Online: 7 March 2024
Competing interests
: Y.W. and G.S. have filed a patent application based on evolved PEmax variants as inventors (European Patent Application No. EP24152221.8). G.S. is a scientific advisor to Prime Medicine. The remaining authors declare no competing interests.